Drug-resistant childhood-onset epilepsies and disease models for novel drug target discovery (DIAMOND)

Bidragets beskrivning

The World Health Organisation (WHO) classifies epilepsy as a major public health problem. One-third of patients have severe epilepsies, which lead to decreased quality of life and may adversely affect cognitive development, especially in children. There is a significant need to develop treatment options for severe epilepsies. We will combine clinical data and patient-derived disease models to identify previously unknown causes and mechanisms of severe epilepsy. This project will be conducted by the Paediatric Neurology Group from the Oulu University Hospital and University of Oulu and the Epilepsia Helsinki Team from the Helsinki University Hospital (HUS) in collaboration with the University of Helsinki, Finland. We aim to find ways to understand, treat, and prevent severe epilepsy and thus alleviate the high burden of severe epilepsy on individuals and their families and on society.
Visa mer

Startår

2025

Slutår

2029

Beviljade finansiering

Rollen i Finlands Akademis konsortium

Övriga parter i konsortiet

Leader
Uleåborgs universitet (369391)
499 390 €

Finansiär

Finlands Akademi

Typ av finansiering

Akademiprojekt

Beslutfattare

Forskningsrådet för biovetenskap, hälsa och miljö
16.06.2025

Övriga uppgifter

Finansieringsbeslutets nummer

369453

Forskningsområden

Kliiniset lääketieteet